This study used bioinformatics analyses and experimental validation to systematically investigate the regulatory roles and underlying mechanisms of long noncoding RNAs (lncRNAs) functioning as competitive endogenous RNAs (ceRNAs) in ischemic stroke.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This study used bioinformatics analyses and experimental validation to systematically investigate the regulatory roles and underlying mechanisms of long noncoding RNAs (lncRNAs) functioning as competitive endogenous RNAs (ceRNAs) in ischemic stroke.
This study aims to investigate the regulatory roles and underlying mechanisms of lncRNAs acting as ceRNAs in ischemic stroke. Based on the ceRNA hypothesis, lncRNAs, miRNAs, and mRNAs were identified as components of a regulatory network involved in stroke. Key lncRNAs from the resulting subnetwork were selected for detailed analysis. Functional enrichment analysis using Gene Ontology and pathway mapping through the Kyoto Encyclopedia of Genes and Genomes revealed critical interactions within the lncRNA-associated ceRNA network. Key pathways, including calcium signaling, gap junction signaling, and neuroactive ligand receptor interaction, were further validated using Western blot analysis. The constructed ceRNA network comprised 334 lncRNAs, miRNAs, and mRNAs, with functional enrichment analysis predicting their biological roles. Three lncRNAs with high degree centrality were selected to construct a representative ceRNA subnetwork. Western blot analysis revealed that, compared to the sham group, the expression levels of key proteins -- CaMKII, calmodulin, CX36, PKC, CX43, GRIA3, GABRA6, and NPY1R were significantly downregulated in the model group, while the expression of CaN was significantly upregulated (P < 0.05). These findings suggest that lncRNAs are significantly involved in stroke pathogenesis. In conclusion, lncRNAs acting as ceRNAs serve critical regulatory roles in the pathogenesis of ischemic stroke.
Ischemic stroke, a prevalent neurological disorder, leads to permanent brain damage, long-term disability, or death1,2,3,4. MicroRNAs (miRNAs or miR), long noncoding RNAs (lncRNAs), and messenger RNAs (mRNA) form RNA-mediated regulatory networks5,6,7,8. These molecules regulate cellular functions through various complex mechanisms9,10are increasingly recogn....
Access restricted. Please log in or start a trial to view this content.
The animal experiments were approved by the Experimental Ethics Committee of Anhui University of Chinese Medicine (license number: AHUCM-rats-2024006) and conducted in accordance with institutional guidelines and JoVE's animal use standards. Forty male SPF-grade SD rats (220 g ± 30 g) were used in this study. The reagents and equipment used are listed in the Table of Materials.
1. Experimental animals
Access restricted. Please log in or start a trial to view this content.
The success rate verification experimental results of each group of rat models are shown in Figure 1. After modeling, neurological function scoring was performed on the rats (Figure 1A). The model group exhibited severe neurological deficits, and those with scores ranging from 1 to 3 were included in subsequent experiments. Figure 1B and C show the TTC staining results, with red representing normal brain tissue and white indicating .......
Access restricted. Please log in or start a trial to view this content.
To investigate the molecular mechanisms underlying stroke pathogenesis and identify potential diagnostic and therapeutic targets, RNA-Seq and small RNA-Seq (sRNA-Seq) analyses were conducted on brain tissues from rats following MCAO. This study primarily aims to investigate the complex regulatory networks involving lncRNAs, miRNAs, and mRNAs. A comprehensive analysis of the RNA-Seq and sRNA-Seq datasets from MCAO-induced rat brain tissues was conducted to elucidate the lncRNA-miRNA-mRNA regulatory network. An extensive n.......
Access restricted. Please log in or start a trial to view this content.
The authors state that there are no competing interests.
This manuscript was supported by the Anhui Province Academic Leader Reserve Candidate Funding Project (No.2022H287), Anhui Provincial Health Research Key Project (Reference: AHWJ2022a013), Anhui Provincial College Natural Science Research Key Project (NO.2023AH050745), and the Anhui Provincial Hygiene and Health Outstanding Talents Project (NO. ahsjhmypygc20230074).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 2% (w/v) TTC staining solution | Beijing Kangle Clone Biotechnology Co., Ltd. | 20230805 | TTC staining |
| 4% (w/v) paraformaldehyde solution | Beyotime | P0099 | Fixed brain tissue |
| 40 male SPF-grade SD Rats | Hagzhou Ziyuan Laboratory Animal Breeding Co.,Ltd | SCXK [zhe] 2024-0004 | laboratory animal |
| 5% skimmed milk powder | Scientific Phygene | PH1519 | WB |
| agarose electrophoresis system | Beijing Liuyi Biotechnology Co., Ltd. | DYCP-44P | WB |
| automatic exposure instrument | Shanghai Peiqing Technology Co., Ltd. | JS-M6P | WB |
| Automatic exposure meter | Shanghai Peiqing Technology Co., LTD | JS-M6P | WB |
| Automatic ice maker | Changshu City Xueke Electric Appliance Co., LTD | IMS-20 | WB |
| Calmodulin | Affinity | 49B2443 | WB |
| CamKII | Affinity | 14G0796 | WB |
| centrifuge | Haimen Qilinbeier Instrument Manufacturing Co., Ltd. | LX 300 | WB |
| clusterProfiler package | Bioconductor | clusterProfiler_4.17 | enrichment analyses |
| CX36 | ZENBIO | N24AP24 | WB |
| CX43 | ZENBIO | M08NO01 | WB |
| ECL ultra-sensitive chemiluminescence kit | biosharp | BL520B | WB |
| Electric thermostatic air drying oven | Shanghai Sanfa Scientific Instrument Co., LTD | DHG-9070 | WB |
| Electrophoresis apparatus | Shanghai Tianeng Technology Co., LTD. (Tanon) | EPS300 | WB |
| electrophoresis apparatus | Shanghai Tanon Science & Technology Co., Ltd. | EPS300 | WB |
| electrophoresis tank | Shanghai Tanon Science & Technology Co., Ltd. | VE-180 | WB |
| GABRA6 | Affinity | 46V5371 | WB |
| Goat Anti-mouse IgG | Zs-BIO | 142637 | WB |
| Goat Anti-Rabbit IgG | Zs-BIO | 139931 | WB |
| GRIA3 | Affinity | 0C33051 | WB |
| High speed refrigerated centrifuge | Anhui Jiawen instrument equipment Co., LTD | JW-3021HR | WB |
| HiSeq 2500 system | illumina | / | RNA high-throughput sequencing |
| ImageJ software | National Institutes of Health | ImageJ 1.54k | TTC staining |
| Magnetic heating agitator | Changzhou city and instrument factory | JJ-79-1 | WB |
| Micropipette | Germany Eppendorf | / | WB |
| Normal temperature micro centrifuge | Haimen Qi Limber Instrument Manufacturing Co., LTD. LX300 | LX300 | WB |
| NPY1R | Affinity | 2D38248 | WB |
| pipette | eppendorf | 0.5-10ul | WB |
| PKC | Affinity | 17E3745 | WB |
| pre-stained protein Marker | biosharp | BL712C | WB |
| PVDF membrane | Millipore | IPVH00010 | WB |
| Ribo-Zero rRNA Removal kit | Illumina, San Diego, California, USA | / | RNA extraction |
| RIPA lysate | Biosharp | BL504A | WB |
| Sodium pentobarbital | Beijing Think-Far Technology Co., Ltd. | MERCK | anesthetic |
| transfer membrane instrument | Shanghai Tanon Science & Technology Co., Ltd. | VE-186 | WB |
| Transmembrane apparatus | Shanghai Tianeng Technology Co., LTD. (Tanon) | VE-186 | WB |
| β-actin | Zs-BIO | 19AW0505 | WB |
Access restricted. Please log in or start a trial to view this content.